122 related articles for article (PubMed ID: 11169148)
1. Expression of CD31, Met/hepatocyte growth factor receptor and bone morphogenetic protein in bone metastasis of osteosarcoma.
Arihiro K; Inai K
Pathol Int; 2001 Feb; 51(2):100-6. PubMed ID: 11169148
[TBL] [Abstract][Full Text] [Related]
2. Fas expression inversely correlates with metastatic potential in osteosarcoma cells.
Worth LL; Lafleur EA; Jia SF; Kleinerman ES
Oncol Rep; 2002; 9(4):823-7. PubMed ID: 12066216
[TBL] [Abstract][Full Text] [Related]
3. Hepatocyte growth factor up-regulates the expression of the bone morphogenetic protein (BMP) receptors, BMPR-IB and BMPR-II, in human prostate cancer cells.
Ye L; Lewis-Russell JM; Davies G; Sanders AJ; Kynaston H; Jiang WG
Int J Oncol; 2007 Feb; 30(2):521-9. PubMed ID: 17203235
[TBL] [Abstract][Full Text] [Related]
4. Expression of bone morphogenetic proteins by osteoinductive and non-osteoinductive human osteosarcoma cells.
Raval P; Hsu HH; Schneider DJ; Sarras MP; Masuhara K; Bonewald LF; Anderson HC
J Dent Res; 1996 Jul; 75(7):1518-23. PubMed ID: 8876605
[TBL] [Abstract][Full Text] [Related]
5. Expression of hepatocyte growth factor and the proto-oncogenic receptor c-Met in canine osteosarcoma.
Fieten H; Spee B; Ijzer J; Kik MJ; Penning LC; Kirpensteijn J
Vet Pathol; 2009 Sep; 46(5):869-77. PubMed ID: 19429984
[TBL] [Abstract][Full Text] [Related]
6. Expression of bone morphogenetic protein and its receptors in osteosarcoma and malignant fibrous histiocytoma.
Mehdi R; Shimizu T; Yoshimura Y; Gomyo H; Takaoka K
Jpn J Clin Oncol; 2000 Jun; 30(6):272-5. PubMed ID: 10939432
[TBL] [Abstract][Full Text] [Related]
7. Expression of bone morphogenetic proteins and receptors in sarcomas.
Guo W; Gorlick R; Ladanyi M; Meyers PA; Huvos AG; Bertino JR; Healey JH
Clin Orthop Relat Res; 1999 Aug; (365):175-83. PubMed ID: 10627702
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of bone morphogenetic activity in osteosarcoma tissue.
Yoshikawa H; Takaoka K; Masuhara K; Ono K; Sakamoto Y
Cancer; 1988 Feb; 61(3):569-73. PubMed ID: 3422172
[TBL] [Abstract][Full Text] [Related]
9. The expression of bone morphogenetic proteins in osteosarcoma and its relevance as a prognostic parameter.
Sulzbacher I; Birner P; Trieb K; Pichlbauer E; Lang S
J Clin Pathol; 2002 May; 55(5):381-5. PubMed ID: 11986346
[TBL] [Abstract][Full Text] [Related]
10. Expression of bone formation-related molecules in a newly established protein-independent osteosarcoma.
Yanagawa T; Watanabe H; Shinozaki T; Nakajima T; Takagishi K
Int J Oncol; 2001 Jun; 18(6):1195-205. PubMed ID: 11351251
[TBL] [Abstract][Full Text] [Related]
11. Relation between histological intensity of transforming growth factor-beta isoforms in human osteosarcoma and the rate of lung metastasis.
Yang RS; Wu CT; Lin KH; Hong RL; Liu TK; Lin KS
Tohoku J Exp Med; 1998 Feb; 184(2):133-42. PubMed ID: 9605020
[TBL] [Abstract][Full Text] [Related]
12. Compactin and simvastatin, but not pravastatin, induce bone morphogenetic protein-2 in human osteosarcoma cells.
Sugiyama M; Kodama T; Konishi K; Abe K; Asami S; Oikawa S
Biochem Biophys Res Commun; 2000 May; 271(3):688-92. PubMed ID: 10814523
[TBL] [Abstract][Full Text] [Related]
13. The Met/HGF receptor is over-expressed in human osteosarcomas and is activated by either a paracrine or an autocrine circuit.
Ferracini R; Di Renzo MF; Scotlandi K; Baldini N; Olivero M; Lollini P; Cremona O; Campanacci M; Comoglio PM
Oncogene; 1995 Feb; 10(4):739-49. PubMed ID: 7862451
[TBL] [Abstract][Full Text] [Related]
14. The effect of bone morphogenetic protein-2 on osteosarcoma metastasis.
Gill J; Connolly P; Roth M; Chung SH; Zhang W; Piperdi S; Hoang B; Yang R; Guzik H; Morris J; Gorlick R; Geller DS
PLoS One; 2017; 12(3):e0173322. PubMed ID: 28264040
[TBL] [Abstract][Full Text] [Related]
15. Transcriptional Profiling Identifies the Signaling Axes of IGF and Transforming Growth Factor-b as Involved in the Pathogenesis of Osteosarcoma.
Yang R; Piperdi S; Zhang Y; Zhu Z; Neophytou N; Hoang BH; Mason G; Geller D; Dorfman H; Meyers PA; Healey JH; Phinney DG; Gorlick R
Clin Orthop Relat Res; 2016 Jan; 474(1):178-89. PubMed ID: 26463566
[TBL] [Abstract][Full Text] [Related]
16. Increased expression of insulin-like growth factor-1 receptor is correlated with tumor metastasis and prognosis in patients with osteosarcoma.
Wang YH; Han XD; Qiu Y; Xiong J; Yu Y; Wang B; Zhu ZZ; Qian BP; Chen YX; Wang SF; Shi HF; Sun X
J Surg Oncol; 2012 Mar; 105(3):235-43. PubMed ID: 21866554
[TBL] [Abstract][Full Text] [Related]
17. Influence of BMPs on the formation of osteoblastic lesions in metastatic prostate cancer.
Feeley BT; Gamradt SC; Hsu WK; Liu N; Krenek L; Robbins P; Huard J; Lieberman JR
J Bone Miner Res; 2005 Dec; 20(12):2189-99. PubMed ID: 16294272
[TBL] [Abstract][Full Text] [Related]
18. Smad7 mediates inhibition of Saos2 osteosarcoma cell differentiation by NFkappaB.
Eliseev RA; Schwarz EM; Zuscik MJ; O'Keefe RJ; Drissi H; Rosier RN
Exp Cell Res; 2006 Jan; 312(1):40-50. PubMed ID: 16259979
[TBL] [Abstract][Full Text] [Related]
19. Osteogenic protein-1 stimulates mRNA levels of BMP-6 and decreases mRNA levels of BMP-2 and -4 in human osteosarcoma cells.
Honda Y; Knutsen R; Strong DD; Sampath TK; Baylink DJ; Mohan S
Calcif Tissue Int; 1997 Mar; 60(3):297-301. PubMed ID: 9069169
[TBL] [Abstract][Full Text] [Related]
20. RANKL directly induces bone morphogenetic protein-2 expression in RANK-expressing POS-1 osteosarcoma cells.
Wittrant Y; Lamoureux F; Mori K; Riet A; Kamijo A; Heymann D; Redini F
Int J Oncol; 2006 Jan; 28(1):261-9. PubMed ID: 16328004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
